AIMS: The purpose of this study was to assess the relationship between calcium scoring (CS) and multi-slice computed tomography coronary angiography (MSCTA) and to determine if MSCTA has an incremental prognostic value to CS. METHODS AND RESULTS: In 432 patients (59% male, age 58 +/- 11 years) referred for cardiac evaluation owing to suspected coronary artery disease (CAD), CS and 64-slice MSCTA were performed. The following events were combined in a composite endpoint: all-cause mortality, non-fatal infarction, and unstable angina requiring revascularization. CS was 0 in 147 (34%) patients, CS 1-99 was present in 122 (28%), CS 100-399 in 75 (17%), CS 400-999 in 56 (13%), and CS > or = 1000 in 32 (7%). MSCTA was normal in 133 (31%) patients, MSCTA 30-50% stenosis was observed in 190 (44%), and MSCTA > or =50% stenosis in 109 (25%). During follow-up [median 670 days (25th-75th percentile: 418-895)], an event occurred in 21 patients (4.9%). After multivariate correction for CS, MSCTA > or = 50% stenosis, the number of diseased segments, obstructive segments, and non-calcified plaques were independent predictors with an incremental prognostic value to CS. CONCLUSION: MSCTA provides additional information to CS regarding stenosis severity and plaque composition. This additional information was shown to translate into incremental prognostic value over CS.
AIMS: The purpose of this study was to assess the relationship between calcium scoring (CS) and multi-slice computed tomography coronary angiography (MSCTA) and to determine if MSCTA has an incremental prognostic value to CS. METHODS AND RESULTS: In 432 patients (59% male, age 58 +/- 11 years) referred for cardiac evaluation owing to suspected coronary artery disease (CAD), CS and 64-slice MSCTA were performed. The following events were combined in a composite endpoint: all-cause mortality, non-fatal infarction, and unstable angina requiring revascularization. CS was 0 in 147 (34%) patients, CS 1-99 was present in 122 (28%), CS 100-399 in 75 (17%), CS 400-999 in 56 (13%), and CS > or = 1000 in 32 (7%). MSCTA was normal in 133 (31%) patients, MSCTA 30-50% stenosis was observed in 190 (44%), and MSCTA > or =50% stenosis in 109 (25%). During follow-up [median 670 days (25th-75th percentile: 418-895)], an event occurred in 21 patients (4.9%). After multivariate correction for CS, MSCTA > or = 50% stenosis, the number of diseased segments, obstructive segments, and non-calcified plaques were independent predictors with an incremental prognostic value to CS. CONCLUSION: MSCTA provides additional information to CS regarding stenosis severity and plaque composition. This additional information was shown to translate into incremental prognostic value over CS.
Authors: E di Cesare; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; L Natale; A Romagnoli; V Russo; F Sardanelli; F Cademartiri Journal: Radiol Med Date: 2012-04-01 Impact factor: 3.469
Authors: E Maffei; C Martini; S De Crescenzo; T Arcadi; A Clemente; E Capuano; A Rossi; R Malagò; N Mollet; A Weustink; C Tedeschi; L La Grutta; S Seitun; A Igoren Guaricci; F Cademartiri Journal: Radiol Med Date: 2010-06-23 Impact factor: 3.469
Authors: E Maffei; S Seitun; C Martini; A Aldrovandi; G Cervellin; C Tedeschi; A Guaricci; G Messalli; O Catalano; F Cademartiri Journal: Radiol Med Date: 2011-03-07 Impact factor: 3.469
Authors: Wehab Ahmed; Michiel A de Graaf; Alexander Broersen; Pieter H Kitslaar; Elco Oost; Jouke Dijkstra; Jeroen J Bax; Johan H C Reiber; Arthur J Scholte Journal: Int J Cardiovasc Imaging Date: 2014-08-27 Impact factor: 2.357
Authors: Olivier F Clerc; Basil P Kaufmann; Mathias Possner; Riccardo Liga; Jan Vontobel; Fran Mikulicic; Christoph Gräni; Dominik C Benz; Tobias A Fuchs; Julia Stehli; Aju P Pazhenkottil; Oliver Gaemperli; Philipp A Kaufmann; Ronny R Buechel Journal: Eur Radiol Date: 2017-05-12 Impact factor: 5.315
Authors: Fleur R de Graaf; Jacob M van Werkhoven; Joëlla E van Velzen; M Louisa Antoni; Mark J Boogers; Lucia J Kroft; Albert de Roos; Martin J Schalij; J Wouter Jukema; Ernst E van der Wall; Joanne D Schuijf; Jeroen J Bax Journal: J Nucl Cardiol Date: 2010-08-06 Impact factor: 5.952